Stage 1 Cancer Detection
The IvyGene™ test is a simple blood test that confirms the presence of cancer, as early as stage 1, and gives measurable information about cancer. It assesses the probability that your body is already making cancer cells by looking for a change in your DNA.
The IvyGene™ test has been validated with four (4) cancer types: breast, colon, liver and lung cancers. The presence of other cancer types may also result in an elevated IvyGene™ Score.
Read the White Paper regarding the Performance Characteristics of the IvyGene test.
Conferences, News, & Events
Alcami Donates to Wilmington Firefighters’ Cancer Detection
Durham-based Alcami has donated $15,000 to the Wilmington, North Carolina Fire Department to help fund IvyGene cancer screenings for firefighters, who face above-average risk of developing cancer.
The building blocks of IvyGene were published in Nature Materials
Learn more about DNA Methylation and how this technology is being used in revolutionary new ways. Visit the link to learn more: www.nature.com/nmat
Dhruvajyoti Roy, PhD, director of technology for LAM, owners of the IvyGene technology, agrees that the combination vaccine has potential for clinical development.
Stop by and visit our booth at our upcoming conferences.
American Academy of Anti-Aging Medicine (A4M)
December 13-15, 2018 – Las Vegas, NV